glp-1 produced by Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 receptor agonists and next-generation

This results in coordinated metabolic improvements via tissue-specific activation of signalling pathways that improve glucose homeostasis, decrease inflammation, and help to improve overall cardiovascular and metabolic health

The biggest feature of Mounjaro is that it is a 'dual agonist'

Weeks 1 to 4: 20 units (0.2 mL) once weekly Weeks 5 to 8: 40 units (0.4 mL) once weekly Weeks 9 to 12: 70 units (0.7 mL) once weekly Weeks 13 to 16: 90 units (0.9 mL) once weekly These are unit measurements based on insulin syringe markings

Simultaneously, monitor by UV to assess the purity and MS to confirm the peptide's molecular weight and sequence

Limited research has been conducted, and Whyte says more large studies are needed to show whether or not treatment is effective in diverse populations